<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Krittika Tanyasaensook และผู้แต่งคนอื่นๆ. (2007) Primary response and saefty of 90yitrium ibritumomab tiuxetan followed by combined chemotherapy of cyclophosphamide, doxorubicin, vincristine, and prednisolone for diffuse large B-Cell lymphoma. Chulalongkorn University:ม.ป.ท.</APA><Chicago>Krittika Tanyasaensook และผู้แต่งคนอื่นๆ. 2007. Primary response and saefty of 90yitrium ibritumomab tiuxetan followed by combined chemotherapy of cyclophosphamide, doxorubicin, vincristine, and prednisolone for diffuse large B-Cell lymphoma. ม.ป.ท.:Chulalongkorn University;</Chicago><MLA>Krittika Tanyasaensook และผู้แต่งคนอื่นๆ.  Primary response and saefty of 90yitrium ibritumomab tiuxetan followed by combined chemotherapy of cyclophosphamide, doxorubicin, vincristine, and prednisolone for diffuse large B-Cell lymphoma.  ม.ป.ท.:Chulalongkorn University, 2007. Print.</MLA></bibliography></xml>
